Marian Loveday
Overview
Explore the profile of Marian Loveday including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
682
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mphothulo N, Hlangu S, Furin J, Moshabela M, Loveday M
BMC Health Serv Res
. 2025 Jan;
25(1):122.
PMID: 39844137
Background: Despite advances in drug-resistant tuberculosis (DR-TB) diagnosis, treatment, and service delivery, individuals with DR-TB often face significant socioeconomic and psychosocial challenges due to limited resources. These challenges can hinder...
2.
Loveday M, Gandhi N, Khan P, Theron G, Hlangu S, Holloway K, et al.
EClinicalMedicine
. 2024 Sep;
76:102821.
PMID: 39290633
Background: There have been no detailed descriptions of infants born to mothers treated for drug resistant TB in pregnancy. Critical case history assessment is important to identify risks and guide...
3.
Loveday M, Hlangu S, Manickchund P, Govender T, Furin J
BMC Infect Dis
. 2024 Aug;
24(1):819.
PMID: 39138390
Background: Despite HIV's evolution to a chronic disease, the burden of advanced HIV disease (AHD, defined as a CD4 count of < 200 cells/uL or WHO clinical Stage 3 or...
4.
van de Water B, Brooks M, Matji R, Ncanywa B, Dikgale F, Abuelezam N, et al.
Implement Sci Commun
. 2024 Apr;
5(1):40.
PMID: 38627799
Background: The use of systems engineering tools, including the development and use of care cascades using routinely collected data, process mapping, and continuous quality improvement, is used for frontline healthcare...
5.
Naidoo K, Perumal R, Cox H, Mathema B, Loveday M, Ismail N, et al.
Lancet Infect Dis
. 2024 Mar;
24(9):e559-e575.
PMID: 38527475
Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of...
6.
Hasan N, Nourse C, Schaaf H, Bekker A, Loveday M, Alcantara Gabardo B, et al.
Lancet Child Adolesc Health
. 2024 Mar;
8(5):369-378.
PMID: 38522446
Infants born to mothers with tuberculosis disease are at increased risk of developing tuberculosis disease themselves. We reviewed published studies and guidelines on the management of these infants to inform...
7.
Dickson L, Le Roux S, Mitrani L, Hill J, Jassat W, Cox H, et al.
BMJ Open
. 2023 Nov;
13(11):e067121.
PMID: 37977868
Objectives: Treatment for multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) is increasingly transitioning from hospital-centred to community-based care. A national policy for decentralised programmatic MDR/RR-TB care was adopted in South Africa in 2011. We...
8.
Myburgh H, Baloyi D, Loveday M, Meehan S, Osman M, Wademan D, et al.
PLOS Glob Public Health
. 2023 Mar;
3(2):e0001357.
PMID: 36963071
Tuberculosis (TB) is a leading cause of death globally. In 2015, the World Health Organization hailed patient-centred care as the first of three pillars in the End TB strategy. Few...
9.
Nicholson T, Hoddinott G, Seddon J, Claassens M, van der Zalm M, Lopez E, et al.
Syst Rev
. 2023 Feb;
12(1):23.
PMID: 36814335
Background: Tuberculosis (TB)-associated mortality in South Africa remains high. This review aimed to systematically assess risk factors associated with death during TB treatment in South African patients. Methods: We conducted...
10.
Le Roux S, Jassat W, Dickson L, Mitrani L, Cox H, Mlisana K, et al.
BMJ Glob Health
. 2023 Jan;
7(12).
PMID: 36593649
Objective: Champions are recognised as important to driving organisational change in healthcare quality improvement initiatives in high-income settings. In low-income and middle-income countries with a high disease burden and constrained...